BCM
AKYA

Bridgeway Capital Management’s Akoya BioSciences AKYA Stock Holding History

Bridgeway Capital Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-105,600
Closed -$242K – 1175
2024
Q4 		$242K Hold
105,600
– – 0.01% 966
2024
Q3 		$287K Sell
105,600
-74,000
-41% -$181K 0.01% 984
2024
Q2 		$420K Buy
179,600
+159,100
+776% +$507K 0.01% 897
2024
Q1 		$96.1K Buy
+20,500
New +$106K ﹤0.01% 1211

Other funds holding AKYA

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return

Bridgeway Capital Management's AKYA Position: Q1 2025 in Review

Bridgeway Capital Management sold out of Akoya BioSciences (AKYA) in Q1 2025, closing a stake of 105,600 shares — an estimated $242K sold.

Bridgeway Capital Management first reported a position in AKYA in Q1 2024 and held it in 4 quarters. The position peaked at $420K in Q2 2024. 64 funds tracked by Wall St. Rank hold AKYA as of Q1 2025.

  • Bridgeway Capital Management reported no remaining Akoya BioSciences position as of Q1 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 105,600 Akoya BioSciences shares in Q1 2025, an estimated $242K.
  • Bridgeway Capital Management first reported a position in Akoya BioSciences in Q1 2024 and held it in 4 quarters.
  • Bridgeway Capital Management's Akoya BioSciences position peaked at $420K in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.